About
The ENDOLEASE project, a spin-off initiative from University Hospital Würzburg, aims to revolutionize drug delivery and minimize unwanted side effects. Conventional systemic drug administration often causes adverse effects in other organs, reducing its overall efficacy. ENDOLEASE addresses this issue by developing a resorbable implant that is inserted directly into the artery. This implant delivers active substances straight into the bloodstream, ensuring targeted and effective therapy, particularly for conditions like heart attacks, strokes, and cancer.
Technologies
Mobile Friendly
Google Font API
WordPress.org
Nginx
Keywords
medical equipment manufacturing
vascular system
superselective drug delivery
medical equipment and supplies manufacturing
bioresorbable materials
pharmaceuticals
systemic side effects
biodegradable implant
fda approved materials
biomedical startup
medical validation
biodegradable materials
vascular drug delivery
medical research
medical innovation
local drug release
biotech
material optimization
local chemotherapy
biomedical innovation
targeted cancer therapy
intra-arterial drug delivery
vascular implants
b2b
biofabrication
medical device development
vascular drug implant
targeted drug delivery
medical devices
clinical application
Company Information
-
Employees 4
